The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
KRYS · Healthcare · Narrow moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
PBH · Healthcare · Narrow moat
Wonderful & reasonably priced
| Measure | KRYS | ANIP | SOLV | PBH |
|---|---|---|---|---|
| Moat Score (0–100) | 62 (highest) | 62 (highest) | 62 (highest) | 62 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 100 (highest) | 80 | 64 | 48 |
| Pricing power | — | 94 (highest) | 94 (highest) | 94 (highest) |
| Returns on capital | 4 | 14 | 38 (highest) | 13 |
| Balance-sheet safety | 100 (highest) | 57 | 79 | 62 |
| Capital allocation | 44 | 67 | 37 | 92 (highest) |
| 7956% above value if growth stopped today | 377% above value if growth stopped today | 26% below value if growth stopped today (largest discount to value if growth stopped today) | 7% below value if growth stopped today | |
| Market cap | $9.8B | $1.7B | $13.5B | $2.4B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2026 |